RT Journal Article
SR Electronic
T1 Wastewater-Based Epidemiological Modeling for Continuous Surveillance of COVID-19 Outbreak
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.19.21265221
DO 10.1101/2021.10.19.21265221
A1 Mehrdad Fazli
A1 Samuel Sklar
A1 Michael D. Porter
A1 Brent A. French
A1 Heman Shakeri
YR 2021
UL http://medrxiv.org/content/early/2021/10/20/2021.10.19.21265221.abstract
AB Using wastewater surveillance as a continuous pooled sampling technique has been in place in many countries since the early stages of the outbreak of COVID-19. Since the beginning of the outbreak, many research works have emerged, studying different aspects of viral SARS-CoV-2 DNA concentrations (viral load) in wastewater and its potential as an early warning method. However, one of the questions that has remained unanswered is the quantitative relation between viral load and clinical indicators such as daily cases, deaths, and hospitalizations. Few studies have tried to couple viral load data with an epidemiological model to relate the number of infections in the community to the viral burden. This paper proposes a stochastic wastewater-based SEIR model to showcase the importance of viral load in the early detection and prediction of an outbreak in a community. We built three models based on whether or not they use the case count and viral load data and compared their simulations and forecasting quality. Our results demonstrate that a simple SEIR model based on viral load data can reliably predict the number of infections in the future. Therefore, wastewater-based surveillance is a promising way of monitoring the spread of COVID-19 and can provide city officials with timely information about the circulation of COVID-19 in the community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to thank the Ivy Foundation COVID-19 translational research fund for supporting this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the data along with the codes in R can be found in the GitHub repository of the project. https://github.com/Shakeri-Lab/COVID-SEIR